Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:493-498

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsushita, H.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsushita, H.
Right arrow Articles by Ogihara, T.

(Hypertension. 1998;31:493.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Inhibition of Growth of Human Vascular Smooth Muscle Cells by Overexpression of p21 Gene Through Induction of Apoptosis

Hidetsugu Matsushita; Ryuichi Morishita; Iwao Kida; Motokuni Aoki; Shin-ichiro Hayashi; Naruya Tomita; Kei Yamamoto; Atsushi Moriguchi; Asao Noda; Yasufumi Kaneda; Jitsuo Higaki; Toshio Ogihara

From the Department of Geriatric Medicine, Osaka University Medical School, Suita, Japan (H.M., R.M., I.K., M.A., S.H., N.T., K.Y., A.M., J.H., T.O.), the Department of Radiation Biophysics, Kobe University, Kobe, Japan (A.N.), and the Institute for Cellular and Molecular Biology and Osaka University Medical School, Suita, Japan (Y.K.).

Correspondence to Toshio Ogihara, MD, PhD, Chief & Professor, Department of Geriatric Medicine, Osaka University Medical School, 2-2 Yamada-oka, Suita 565, Japan

The senescent cell-derived inhibitor (sdi)-1 protein (p21 product) has been identified as a downstream mediator of the tumor suppressor p53 in the regulation of cell cycle progression through a G1 phase checkpoint. Given the importance of cell cycle inhibition for the treatment of restenosis, in this study we focused on the function of p21 gene in inhibiting proliferation of vascular smooth muscle cells (VSMC). To test the hypothesis, we transfected human p21 gene into human aortic VSMC using hemagglutinating virus of Japan-liposome-mediated transfer. Initially, we examined the successful transfection of human p21 gene into VSMC. p21 protein was increased in VSMC transfected with p21 vector as compared with control vector. Accompanied by increased p21 protein, transfection of p21 vector resulted in a significant decrease in number of VSMC induced by 2% serum (P<.01). Although p21 has been reported to play an important role in the regulation of apoptosis in some cells, apoptosis mediated by p21 is still controversial. Therefore, we hypothesized that overexpression of p21 mediates apoptosis in human VSMC, in addition to the blockade of cell cycle progression. First, we assessed the concordance between morphologic analysis and apoptosis as determined by nuclear staining with Hoechst 33342. Cells transfected with p21 gene exhibited the characteristic features of cell shrinkage, membrane blebbing, and rounding that are typical of apoptotic death. Of greater interest, a significant increase in apoptotic cells was observed in VSMC transfected with p21 vector as compared with control vector (P<.01). These results were confirmed by the measurement of DNA fragmentation. Consistent with nuclear staining, DNA fragmentation in VSMC transfected with human p21 gene was significantly increased as compared with that in VSMC transfected with control vector (P<.05). To study the molecular mechanisms of apoptosis mediated by overexpression of p21 gene, the protein levels of bax, a promoter of apoptosis, and bcl-2, an inhibitor of apoptosis, were also measured by Western blotting. Overexpression of p21 gene significantly increased protein of bax (P<.05), whereas transfection of p21 gene did not alter bcl-2 protein. Importantly, the ratio of bax to bcl-2 was significantly increased in VSMC transfected with human p21 vector as compared with control vector (P<.05). Overall, these results demonstrated that inhibition of VSMC growth by overexpression of human p21 gene was accompanied by induction of apoptosis through an inappropriate increase in bax protein. These results suggest that regulation of cell cycle by p21 may be closely linked to programmed cell death/apoptosis in human VSMC.


Key Words: gene therapy • cell cycle regulatory gene • bax • bcl-2 • remodeling

Abbreviations: DSF = defined serum-free medium • HVJ = hemagglutinating virus of Japan • sdi-1 = senescent cell-derived inhibitor-1 • VSMC = vascular smooth muscle cells




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
T. S. Udayakumar, P. Hachem, M. M. Ahmed, S. Agrawal, and A. Pollack
Antisense MDM2 Enhances E2F1-Induced Apoptosis and the Combination Sensitizes Androgen-Dependent and Androgen-Independent Prostate Cancer Cells to Radiation
Mol. Cancer Res., November 1, 2008; 6(11): 1742 - 1754.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. A. Hruska, S. Mathew, and G. Saab
Bone Morphogenetic Proteins in Vascular Calcification
Circ. Res., July 22, 2005; 97(2): 105 - 114.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
A. Chandiwal, V. Balasubramanian, Z. K. Baldwin, M. S. Conte, and L. B. Schwartz
Gene Therapy for the Extension of Vein Graft Patency: A Review
Vascular and Endovascular Surgery, January 1, 2005; 39(1): 1 - 14.
[Abstract] [PDF]


Home page
Mol. Cell. Biol.Home page
E. R. Vickers, A. Kasza, I. A. Kurnaz, A. Seifert, L. A. H. Zeef, A. O'Donnell, A. Hayes, and A. D. Sharrocks
Ternary Complex Factor-Serum Response Factor Complex-Regulated Gene Activity Is Required for Cellular Proliferation and Inhibition of Apoptotic Cell Death
Mol. Cell. Biol., December 1, 2004; 24(23): 10340 - 10351.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Lin, X. Zhu, F. L. Mclntee, H. Xiao, J. Zhang, M. Fu, and Y. E. Chen
Interferon Regulatory Factor-1 Mediates PPAR{gamma}-Induced Apoptosis in Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 257 - 263.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. B. Davis, Y. Dong, and R. H. Weiss
Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Am J Physiol Cell Physiol, January 1, 2003; 284(1): C16 - C23.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. Nonomura, H. Kohsaka, K. Nasu, Y. Terada, M.-a. Ikeda, and N. Miyasaka
Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21Cip1 gene into the joints
Int. Immunol., June 1, 2001; 13(6): 723 - 731.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Kawauchi, J.-i. Suzuki, R. Morishita, Y. Wada, A. Izawa, N. Tomita, J. Amano, Y. Kaneda, T. Ogihara, S. Takamoto, et al.
Gene Therapy for Attenuating Cardiac Allograft Arteriopathy Using Ex Vivo E2F Decoy Transfection by HVJ-AVE-Liposome Method in Mice and Nonhuman Primates
Circ. Res., November 24, 2000; 87(11): 1063 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. H. Weiss, A. Joo, and C. Randour
p21Waf1/Cip1 Is an Assembly Factor Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation
J. Biol. Chem., March 31, 2000; 275(14): 10285 - 10290.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S.-i. Hayashi, R. Morishita, H. Matsushita, H. Nakagami, Y. Taniyama, T. Nakamura, M. Aoki, K. Yamamoto, J. Higaki, and T. Ogihara
Cyclic AMP Inhibited Proliferation of Human Aortic Vascular Smooth Muscle Cells, Accompanied by Induction of p53 and p21
Hypertension, January 1, 2000; 35(1): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-P. Tsao, S.-J. Huang, J.-L. Chang, J.-T. Hsieh, R.-C. Pong, and S.-L. Chen
Adenovirus-Mediated p21(WAF1/SDII/CIP1) Gene Transfer Induces Apoptosis of Human Cervical Cancer Cell Lines
J. Virol., June 1, 1999; 73(6): 4983 - 4990.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
J.-M. Li and G. Brooks
Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?
Eur. Heart J., March 2, 1999; 20(6): 406 - 420.
[PDF]